Taro's acquisition of Alchemee

On February 22, 2022 Taro Pharmaceutical Industries Ltd. (Taro), a multinational, science-based pharmaceutical company, and Swiss-based Galderma announced that they have signed a definitive agreement for Taro to acquire Alchemee, formerly The Proactiv Company, from Galderma.

Lenz & Staehelin is advising Taro on Swiss law matters. The team is led by Matthias Wolf and Tino Gaberthüel (both M&A) and includes Pascal Hinny, Lukas Aebi (both Tax) and Alex Wille (M&A).

Published: 25 February 2022